Kreps and colleagues’ survey1 of a national sample of US adults provides insights into how we might achieve the level of vaccine uptake needed to prevent the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study lands at a critical moment for US public health. The SARS-CoV-2 pandemic is surging, influenza season is looming, and the delivery of a vaccine to protect against coronavirus disease 2019 (COVID-19), the disease caused by SARS-CoV-2, appears imminent through the US government’s Operation Warp Speed initiative.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Published: October 20, 2020. doi:10.1001/jamanetworkopen.2020.25672
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2020 Opel DJ et al. JAMA Network Open.
Corresponding Author: Douglas J. Opel MD, MPH, Seattle Children’s Research Institute, 1900 Ninth Ave, M/S: JMB-6, Seattle, WA 98101 (email@example.com).
Conflict of Interest Disclosures: Dr Salmon reported receiving personal fees from Merck and grants from Walgreens outside the submitted work. No other disclosures were reported.
You currently have no searches saved.
You currently have no courses saved.